Douglasm Fambrough News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Douglasm fambrough. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Douglasm Fambrough Today - Breaking & Trending Today

Oncorus Inc. (ONCR) Appoints Douglas Fambrough to its Board

Oncorus Inc. (ONCR) Appoints Douglas Fambrough to its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Douglasm Fambrough , Theodore Ted Ashburn , University Of California , Broad Institute , Oncorus Inc , Cornell University , Dicerna Pharmaceuticals , Genomic Research , Novo Nordisk , Chief Executive Officer , Oxford Bioscience Partners , Sirna Therapeutics , Ribx Pharmaceuticals ,

Shareholders Sue Dicerna Pharmaceuticals Over Proposed Merger

Plaintiffs Laurie Volpe and Matthew Hopkins have filed suit separately against defendant Dicerna Pharmaceuticals, Inc. (Dicerna), and their board of ....

New York , United States , Patrickm Gray , Cynthia Smith , Stephen Doberstein , Stephenj Hoffman , Marc Kozin , Laurie Volpe , Adamm Koppel , J Kevin Buchi , Matthew Hopkins , Douglasm Fambrough , Novo Nordisk , Exchange Commission , Securities Exchange , Research Inc , Monteverde Associates , Dicerna Pharmaceuticals Inc , Plaintiffs Laurie Volpe , Dicerna Pharmaceuticals , Martin Freed , Securities Exchange Act , Exchange Act , United States Securities , Southern District , Recommendation Statement ,

hepatitis B

hepatitis B
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

France General , Douglas Fambrough , Gregory Renza , Madhu Kumar , Johnson Johnsonfriday , Codiak Biosciences , Gbola Amusa , Doug Fambrough , Douglasm Fambrough , Brian Abrahams , Gilead Sciences Inc , Advisory Committee On Immunization , Pharmathene Inc , Solar Power Company Array Technologies , Assembly Biosciences Hepb Antiviral Data , International Liver Congress , Centers For Disease , Enochian Biosciences Inc , Arbutus Biopharma Corporation , Assembly Biosciences Inc , Arrowhead Pharmaceuticals Inc , Dynavax Technologies Corporation , Dicerna Pharmaceuticals Inc , Arbutus Biopharma Corp , Health Care , For Hepatitisb Programmonday ,

Dicerna Pharmaceuticals Inc (DRNA) Q1 2021 Earnings Call Transcript

Operator
Good afternoon, ladies and gentlemen, and welcome to the Dicerna Pharmaceuticals First Quarter 2021 Earnings Conference Call. As a reminder, this conference call is being recorded at the company s request.
I will now turn the call over to your host, Will Grammig of Stern IR. Please go ahead.
Lauren Stival
Investor Relations
Thank you, operator. Good afternoon, everyone, and thank you for joining us to review Dicerna s first quarter 2021 financial results and operational highlights. For anyone who hasn t yet had a chance to review our results we issued a press release after the close of trading today, which is available under the investors and media tab on our website at dicerna.com. ....

United States , Robyn Karnauskas , Ed Arce , Doug Pagan , Henry Kranzler , Douglasw Pagan , Stephen Willey , Stephen Willey Stifel , Sheeram Aradhye , Mayank Mamtani , Smith Cowen , Rob Williams Goldman Sachs , Dicerna Gal , Rob Ciappenelli , Jim Weissman , Douglasm Fambrough , Yigal Nochomovitz , Robertd Ciappenelli , Yigal Nochomovitz Citigroup , Jonathan Miller Evercore , Shreeram Aradhye , Yaron Werber , Madhu Kumar , Bob Brown , Mani Foroohar , Jonathan Miller ,

Dicerna Pharmaceuticals Inc (DRNA) Q4 2020 Earnings Call Transcript

Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Dicerna Pharmaceuticals Full year 2020 Earnings Conference Call. As a reminder, this conference is being recorded at the company s request. I will now turn the call over to your host, Ms. Lauren Stival, Senior Director of Investor Relations at Dicerna. Please go ahead.
Lauren Stival
Senior Director of Investor Relations
Thank you, operator. Good afternoon, everyone, and thank you for joining us to review Dicerna s full year 2020 financial results and operational highlights. For anyone who hasn t yet had a chance to review our results, we issued a press release after the close of trading today, which is available under the investors and media tab on our website at dicerna.com. You may also listen to this conference call via webcast on our website, which will be archived beginning approximately two hours after the call is completed. Speaking on today s call will be Dicerna s President and ....

United States , Shreeram Aradhye , Doug Pagan , Bob Brown , Dicerna Gal , Doug Fambrough , Douglasm Fambrough , Jim Weissman , Rob Ciappenelli , University Of Pennsylvania Perelman School Medicine , Dicerna Pharmaceuticals , Novo Nordisk , Dicerna Pharmaceuticals Inc , Dicerna Pharmaceuticals Full , Lauren Stival , Senior Director , Investor Relations , Chief Medical Officer , Chief Financial Officer , Chief Operating Officer , Chief Commercial Officer , Chief Scientific Officer , Risk Factors , Chief Executive , Vice President , Chief Medical ,